Living donor liver transplantation for hepatocellular carcinoma: A single-center experience in Taiwan

Transplantation

Volumn 85, Issue 3, 2008, Pages 398-406

  Concejero, Allan ^a   Chen, Chao Long ^a   Wang, Chih Chi ^a   Wang, Shih Ho ^a   Lin, Chih Che ^a   Liu, Yueh Wei ^a   Yang, Chin Hsiang ^a   Yong, Chee Chien ^a   Lin, Tsan Shiun ^a   Jawan, Bruno ^a   Huang, Tung Liang ^a   Cheng, Yu Fan ^a   Eng, Hock Liew ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Hepatocellular carcinoma; Liver transplantation; Milan criteria; Salvage transplantation

Indexed keywords

ADEFOVIR; ALCOHOL; DOXORUBICIN; IODINATED POPPYSEED OIL; LAMIVUDINE; MYCOPHENOLIC ACID; PEGINTERFERON; RIBAVIRIN; STEROID; TACROLIMUS;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAFT REJECTION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVING DONOR; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; TAIWAN;

ADULT; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TAIWAN; TREATMENT OUTCOME;

EID: 40049107604     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181622ff8     Document Type: Article

References (27)

1. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693.
2. Sharma P, Balan V, Hernandez J, et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transplant 2004; 10: 36.
3. Lo CM, Fan ST, Liu CL, et al. The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transplant 2004; 10: 440.
4. Kulik L, Abecassis M. Living donor liver transplantation for hepatocellular carcinoma. Gastroenterology 2004; 127: S277.
5. Chen CL, Chen YS, De Villa VH, et al. Minimal blood loss living donor hepatectomy. Transplantation 2000; 69: 2580.
6. Urata K, Kawasaki S, Matsunami H, et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology 1995; 21: 1317.
7. De Villa VH, Chen CL, Chen YS, et al. Outflow tract reconstruction in living donor liver transplantation. Transplantation 2000; 70: 1604.
8. De Villa VH, Chen CL, Chen YS, et al. Right lobe living donor liver transplantation: Addressing the middle hepatic vein controversy. Ann Surg 2003; 238: 275.
9. Concejero A, Chen CL, Wang CC, et al. Donor graft outflow venoplasty in living donor liver transplantation. Liver Transpl 2006; 12: 264.
10. Carr BI. Hepatocellular carcinoma: Current management and future trends. Gastroenterology 2004; 127: S218.
11. Stadlbauer V, Schaffellner D, Kniepeiss E, et al. Experiences in liver transplantation for hepatocellular carcinoma. Transplant Proc 2004; 36: 195.
12. Wong LL, Tsai N, Limm W, Wong L. Liver transplant for hepatocellular cancer: A treatment for the select few. Clin Transplant 2004; 18: 205.
13. Gondolesi G, Munoz L, Matsumoto C, et al. Hepatocellular carcinoma: A prime indication for living donor liver transplantation. J Gastrointest Surg 2002; 6: 102.
14. Gondolesi G, Roayaie S, Munoz L, et al. Adult living donor liver transplantation for patients with hepatocellular carcinoma: Extending UNOS priority criteria. Ann Surg 2004; 329: 142.
15. Cheng SJ, Pratt DS, Freeman RB Jr., et al. Living-donor versus cadaveric liver transplantation for non-resectable small hepatocellular carcinoma and compensated cirrhosis: A decision analysis. Transplantation 2001; 72: 861.
16. Sarasin FP, Majno PE, Llovet JM, et al. Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and costeffectiveness perspective. Hepatology 2001; 33: 1073.
17. Cheng YF, Huang TL, Chen TY, et al. Impact of pre-operative transarterial embolization on the treatment of hepatocellular carcinoma with liver transplantation. World J Gastroenterol 2005; 11: 1433.
18. Wong LL, Tanaka K, Lau L, Komura S. Pre-transplant treatment of hepatocellular carcinoma: Assessment of tumor necrosis in explanted livers. Clin Transplant 2004; 18: 227.
19. Lo CM, Fan ST, Liu CL, et al. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 2007; 94: 78.
20. Plessier A, Codes L, Consigny Y, et al. Underestimation of the influence of satellite nodules as a risk factor for post-transplantation recurrence in patients with small hepatocellular carcinoma. Liver Transplant 2004; 10: S86.
21. Ravaioli M, Grazi G, Ercolani G, et al. Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. Transplantation 2004; 78: 1780.
22. Sala M, Fuster J, Llovet J, et al. High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplant. Liver Transplant 2004; 10: 1294.
23. Bechstien WO, Guckelberger O, Kling N, et al. Recurrence-free survival after liver transplantation for small hepatocellular carcinoma. Transpl Int 1998; 11: S189.
24. Figueras J, Jaurrieta E, Valls C, et al. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: Outcomes based on indicated treatment strategy. J Am Coll Surg 2000; 190: 580.
25. Yao FY, Farrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394.
26. Jones S, Bechstein WO, Steinmuller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma. Hepatology 2001; 33: 1080.
27. Margarit C, Charco R, Hidalgo E, et al. Liver transplantation for malignant diseases: Selection and pattern of recurrence. World J Surg 2002; 26: 257.